The effect of smoking cessation on airway inflammation in young asthma patients

Clinical and Experimental Allergy

Volumn 44, Issue 3, 2014, Pages 353-361

  Westergaard, C G ^a   Porsbjerg, C ^a   Backer, V ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Airway hyperresponsiveness; Airway inflammation; Asthma; Smoking cessation

Indexed keywords

AIRWAY HYPERRESPONSIVENESS; AIRWAY INFLAMMATION; ASTHMA; SMOKING CESSATION;

ADULT; ASTHMA; BRONCHIAL PROVOCATION TESTS; EXHALATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOPHENOTYPING; INFLAMMATION; LEUKOCYTE COUNT; LEUKOCYTES; MALE; NITRIC OXIDE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SMOKING; SMOKING CESSATION; SPUTUM; TIME FACTORS; YOUNG ADULT;

EID: 84894284531     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12243     Document Type: Article

References (31)

1. McLeish AC, Zvolensky MJ. Asthma and cigarette smoking: a review of the empirical literature. J Asthma 2010; 47:345-61.
2. Chalmers GW, Macleod KJ, Little SA, Thomson LJ, McSharry CP, Thomson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002; 57:226-30.
3. Tomlinson JE, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC. Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax 2005; 60:282-7.
4. Lazarus SC, Chinchilli VM, Rollings NJ et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007; 175:783-90.
5. Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med 2009; 15:39-45.
6. Stǎnescu D, Sanna A, Veriter C et al. Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. Thorax 1996; 51:267-71.
7. Krisiukeniene A, Babusyte A, Stravinskaite K, Lotvall J, Sakalauskas R, Sitkauskiene B. Smoking affects eotaxin levels in asthma patients. J Asthma 2009; 46:470-6.
8. Pavord ID, Brightling CE, Woltmann G, Wardlaw AJ. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 1999; 353:2213-4.
9. Berry M, Morgan A, Shaw DE et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007; 62:1043-9.
10. Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR. Effects of steroid therapy on inflammatory cell subtypes in asthma. Thorax 2010; 65:384-90.
11. Chaudhuri R, Livingston E, McMahon AD et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006; 174:127-33.
12. Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J 2013; 41:716-26.
13. Willemse BW, ten Hacken NH, Rutgers B, Lesman-Leegte IG, Timens W, Postma DS. Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD. Eur Respir J 2004; 24:391-6.
14. Piccillo G, Caponnetto P, Barton S et al. Changes in airway hyperresponsiveness following smoking cessation: comparisons between Mch and AMP. Respir Med 2008; 102:256-65.
15. Tønnesen P, Pisinger C, Hvidberg S et al. Effects of smoking cessation and reduction in asthmatics. Nicotine Tob Res 2005; 7:139-48.
16. Chaudhuri R, McSharry C, McCoard A et al. Role of symptoms and lung function in determining asthma control in smokers with asthma. Allergy 2008; 63:132-5.
17. Miller MR, Hankinson J, Brusasco V et al. Standardisation of spirometry. Eur Respir J 2005; 26:319-38.
18. American Thoracic Society; European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171:912-30.
19. Anderson SD, Brannan J, Spring J et al. A new method for bronchial-provocation testing in asthmatic subjects using a dry powder of mannitol. Am J Respir Crit Care Med 1997; 156(3 Pt 1):758-65.
20. Yan K, Salome C, Woolcock AJ. Rapid method for measurement of bronchial responsiveness. Thorax 1983; 38:760-5.
21. Pavord ID, Pizzichini MM, Pizzichini E, Hargreave FE. The use of induced sputum to investigate airway inflammation. Thorax 1997; 52:498-501.
22. Simpson JL, Scott R, Boyle MJ, Gibson PG. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006; 11:54-61.
23. Juniper EF, Bousquet J, Abetz L, Bateman ED; GOAL Committee. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med 2006; 100:616-21.
24. Bergeron C, Boulet LP, Page N et al. Influence of cigarette smoke on the arginine pathway in asthmatic airways: increased expression of arginase I. J Allergy Clin Immunol 2007; 119:391-7.
25. Robbins RA, Millatmal T, Lassi K, Rennard S, Daughton D. Smoking cessation is associated with an increase in exhaled nitric oxide. Chest 1997; 112:313-8.
26. Jatakanon A, Lim S, Kharitonov SA, Chung KF, Barnes PJ. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53:91-5.
27. Jang AS, Park SW, Kim DJ et al. Effects of smoking cessation on airflow obstruction and quality of life in asthmatic smokers. Allergy Asthma Immunol Res 2010; 2:254-9.
28. Broekema M, ten Hacken NH, Volbeda F et al. Airway epithelial changes in smokers but not in ex-smokers with asthma. Am J Respir Crit Care Med 2009; 180:1170-8.
29. Ghio AJ, Smith CB, Madden MC. Diesel exhaust particles and airway inflammation. Curr Opin Pulm Med 2012; 18:144-50.
30. Telenga ED, Tideman SW, Kerstjens HA et al. Obesity in asthma: more neutrophilic inflammation as a possible explanation for a reduced treatment response. Allergy 2012; 67:1060-8.
31. Lemiere C. Diagnosing occupational asthma: insight from induced sputum. Can J Physiol Pharmacol 2006; 84:1-4.